US HB6965 | 2023-2024 | 118th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on January 11 2024 - 25% progression, died in committee
Action: 2024-01-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 11 2024 - 25% progression, died in committee
Action: 2024-01-12 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to establish requirements with respect to cost sharing for epinephrine injectors under group health plans and group and individual health insurance coverage.
Title
EPIPEN Act Epinephrine’s Pharma Inflated Price Ends Now Act
Sponsors
Rep. Maxwell Frost [D-FL] | Rep. Doris Matsui [D-CA] |
History
Date | Chamber | Action |
---|---|---|
2024-01-12 | House | Referred to the Subcommittee on Health. |
2024-01-12 | House | Sponsor introductory remarks on measure. (CR H127) |
2024-01-11 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and the Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2024-01-11 | House | Introduced in House |
Subjects
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/118th-congress/house-bill/6965/all-info |
Text | https://www.congress.gov/118/bills/hr6965/BILLS-118hr6965ih.pdf |